FAKTOR-OPTIONSSCHEIN - AMGEN | Real-time Boerse Frankfurt Warrants 08:06:10 30/05/2024 pm IST | ||
| 12.03 EUR | +0.08% |
|
| Current month | +14.26% | ||
| 1 month | +13.83% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 30/24/30 | 12.03 | +0.08% |
| 29/24/29 | 12.02 | -1.88% |
| 28/24/28 | 12.25 | -4.15% |
| 27/24/27 | 12.78 | 0.00% |
| 24/24/24 | 12.78 | -0.78% |
Real-time Boerse Frankfurt Warrants
Last update May 30, 2024 at 08:06 pm IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SB01EX |
| ISIN | DE000SB01EX7 |
| Date issued | 09/06/2020 |
| Strike | 225.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.1 € |
|---|---|
| Lowest since issue | 6.3 € |
| Spread | 0.03 € |
| Spread % | 0.25% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
296.4
USD
Average target price
316.3
USD
Spread / Average Target
+6.72%
- Stock Market
- Certificates
- Certificat
